Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea
Clinical trial NCT01019473 · TERMINATED
Trial details
- NCT number
- NCT01019473
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-08-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.